MiniMed Group, Inc. Common Stock
Follow $MMED
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $MMED by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is MMED moving today?
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
MMED overview
Related filings and maps
Congress activity in MMED
No receipt-qualified Congressional disclosure is present for MMED in the cached public ledger.
MMED contract awards, year to date.
Public federal awards linked to this ticker.
MMED lobbying filings, year to date.
Registered lobbying filings matched to MiniMed Group, Inc. Common Stock.